SCHEMBL20914000

SCHEMBL20914000

COc1cccc2oc(-c3c(C(=O)NCC(=O)O)[nH]c4c(-c5ccccc5)c(C(F)(F)F)nn4c3=O)nc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2RL3 Q96RI0 2/20 0.33
▸ TOP2A P11388 1/20 0.33
▸ MAOB P27338 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ HTR3A P46098 2/20 0.32
▸ KCNH2 Q12809 2/20 0.32
▸ TNKS O95271 2/20 0.32
▸ TNKS2 Q9H2K2 2/20 0.32
▸ PARP2 Q9UGN5 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ ARF6 P62330 2/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ MAT2A P31153 1/20 0.31
▸ DGAT1 O75907 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ TACR1 P25103 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914008 0.92 TAAR1 (0.33) F2RL3TOP2AMAOBADORA2AHTR3A
SCHEMBL20818972 0.92 NPC1 (0.35) F2RL3TOP2AADORA2AHTR3AKCNH2
SCHEMBL20837044 0.91 F2RL3 (0.33) F2RL3TOP2AMAOBADORA2AHTR3A
SCHEMBL20837252 0.90 FYN (0.36) F2RL3DGAT1HSD17B10KMT2A
SCHEMBL20914027 0.90 PTGER1 (0.36) F2RL3TOP2AMAOBADORA2AHTR3A
SCHEMBL20819040 0.89 TNKS (0.35) F2RL3TOP2AMAOBADORA2ATNKS
SCHEMBL20914084 0.89 ADORA2A (0.33) F2RL3TOP2AADORA2APDE4BMAT2A
SCHEMBL20913994 0.89 POLB (0.37) F2RL3TOP2AMAOBADORA2ATNKS
SCHEMBL20914091 0.88 TNKS (0.34) F2RL3TOP2ATNKSTNKS2PARP2
SCHEMBL20913948 0.88 PDE4B (0.35) F2RL3TOP2AADORA2AHTR3AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 F2RL3 1469/4885TOP2A 4537/4885MAOB 832/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 F2RL3 1469/4885TOP2A 4537/4885MAOB 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback